# ALX Oncology Holdings Inc: Form 8-K, filed Oct 4, 2024

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: 8-K
- Filed: 2024-10-04
- Accepted by EDGAR: Oct 4, 2024, 13:00 ET
- Period: 2024-09-30
- Accession: 0000950170-24-112734
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000095017024112734/alxo-20240930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000095017024112734/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000095017024112734/alxo-20240930.htm

Filed Oct 4, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-112734. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.